TINA MONTEE: Open Payments
NPI 1942616016 · SULLIVAN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$607 in 29 payments from 18 companies in 2025. Trend: 2023 $963 · 2024 $572 · 2025 $607
Food & beverage: $607
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $86 |
| Otsuka America Pharmaceutical, Inc. | 3 | $79 |
| ABBVIE INC. | 3 | $70 |
| PFIZER INC. | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| Radius Health, Inc. | 1 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $29 |
| Phathom Pharmaceuticals, Inc. | 2 | $28 |
| Lundbeck LLC | 1 | $27 |
| Lilly USA, LLC | 1 | $26 |
Products named: REXULTI, VRAYLAR, Ozempic, Tymlos, NURTEC ODT, UBRELVY, XIFAXAN, VOQUEZNA.
Industry payments across MO — which companies pay providers there.
